Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Neurobiology of Disease
|
December 29, 2024
Developmental dysfunction in a preclinical model of Kcnq2 developmental and epileptic encephalopathy
Miaomiao Mao, Nikola Jancovski, Yafit Kushner, et al.
Alzheimer'S Research & Therapy
|
December 27, 2022
The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer's disease: a literature review
Abby L Brand, Paige E Lawler, James G Bollinger, et al.
Frontiers in Pharmacology
|
September 6, 2017
Gabapentin Modulates HCN4 Channel Voltage-Dependence
Han-Shen Tae, Kelly M Smith, A Marie Phillips, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 7, 2022
Using Alzheimer's disease blood tests to accelerate clinical trial enrollment
Suzanne E Schindler, Yan Li, Melody Li, et al.
Annals of Neurology
|
September 16, 2015
Quinidine in the treatment of KCNT1-positive epilepsies
Mohamad A Mikati, Yong-Hui Jiang, Michael Carboni, et al.
JCI Insight
|
September 29, 2022
Antisense oligonucleotide therapy for KCNT1 encephalopathy
Lisseth Estefania Burbano, Melody Li, Nikola Jancovski, et al.
The Journal of Clinical Investigation
|
December 1, 2021
Antisense oligonucleotide therapy reduces seizures and extends life span in an SCN2A gain-of-function epilepsy model
Melody Li, Nikola Jancovski, Paymaan Jafar-Nejad, et al.
Neurology
|
October 14, 2016
Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy
Mark A Corbett, Susannah T Bellows, Melody Li, et al.
Annals of Neurology
|
March 5, 2014
KCNT1 gain of function in 2 epilepsy phenotypes is reversed by quinidine
Carol J Milligan, Melody Li, Elena V Gazina, et al.
Human Mutation
|
October 25, 2017
Gain-of-function HCN2 variants in genetic epilepsy
Melody Li, Snezana Maljevic, A Marie Phillips, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Neurobiology of Disease
|
December 29, 2024
Developmental dysfunction in a preclinical model of Kcnq2 developmental and epileptic encephalopathy
Miaomiao Mao, Nikola Jancovski, Yafit Kushner, et al.
Alzheimer'S Research & Therapy
|
December 27, 2022
The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer's disease: a literature review
Abby L Brand, Paige E Lawler, James G Bollinger, et al.
Frontiers in Pharmacology
|
September 6, 2017
Gabapentin Modulates HCN4 Channel Voltage-Dependence
Han-Shen Tae, Kelly M Smith, A Marie Phillips, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 7, 2022
Using Alzheimer's disease blood tests to accelerate clinical trial enrollment
Suzanne E Schindler, Yan Li, Melody Li, et al.
Annals of Neurology
|
September 16, 2015
Quinidine in the treatment of KCNT1-positive epilepsies
Mohamad A Mikati, Yong-Hui Jiang, Michael Carboni, et al.
JCI Insight
|
September 29, 2022
Antisense oligonucleotide therapy for KCNT1 encephalopathy
Lisseth Estefania Burbano, Melody Li, Nikola Jancovski, et al.
The Journal of Clinical Investigation
|
December 1, 2021
Antisense oligonucleotide therapy reduces seizures and extends life span in an SCN2A gain-of-function epilepsy model
Melody Li, Nikola Jancovski, Paymaan Jafar-Nejad, et al.
Neurology
|
October 14, 2016
Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy
Mark A Corbett, Susannah T Bellows, Melody Li, et al.
Annals of Neurology
|
March 5, 2014
KCNT1 gain of function in 2 epilepsy phenotypes is reversed by quinidine
Carol J Milligan, Melody Li, Elena V Gazina, et al.
Human Mutation
|
October 25, 2017
Gain-of-function HCN2 variants in genetic epilepsy
Melody Li, Snezana Maljevic, A Marie Phillips, et al.
Page
of 4